Core Insights - The "Second International Breast Cancer Research Forum" hosted by Shandong University Qilu Second Hospital focused on breast cancer research, clinical diagnosis, and precision prevention strategies, featuring over 20 expert presentations from 12 countries and regions [1][2][7] Group 1: Event Overview - The forum aimed to create a high-level academic exchange platform addressing key areas in breast cancer research, including clinical diagnosis and innovative treatment methods [1] - Key figures from Shandong University and international experts participated, emphasizing the importance of global collaboration in breast cancer prevention and treatment [2] Group 2: Institutional Goals and Achievements - Shandong University Qilu Second Hospital is transitioning from a disease-centered approach to a health-centered strategy, focusing on medical innovation, talent cultivation, and research成果转化 [1][2] - The hospital showcased its achievements in breast cancer cohort construction, biobank standardization, and digital medicine platform development [2] Group 3: Academic Contributions - The forum featured presentations on various topics, including molecular pathology, treatment innovations, and AI-assisted medical imaging, highlighting the comprehensive nature of breast cancer research [3][4][5][6] - Notable presentations included discussions on the Hippo signaling pathway, metabolic vulnerabilities in luminal breast cancer, and advancements in cell and gene therapy for endocrine diseases [3][4][5] Group 4: Future Directions - The collaboration between the forum and the inaugural editorial board meeting of "Molecular and Digital Medicine" aims to enhance interdisciplinary integration and accelerate the translation of research成果 into clinical practice [7]